Top news
WHO Director-General commends United States decision to support temporary waiver on intellectual property rights for ...
Stopping Drug Patents Has Stopped Pandemics Before
By Laurie Garrett
Fauci warns against discarding trade rules on Covid vaccines
By Kiran Stacey
Biden administration to waive vaccine patent protection - The Washington Post
By Dan Diamond, Tyler Pager & Jeff Stein
All coverage
Industry fights over global vaccine patents are just warming up
By Christopher Rowland
Explainer: COVID-19 vaccine patents dominate global trade talks
By Philip Blenkinsop
All you need to know about the battle over COVID jab IP rights
By Virginia Pietromarchi
TRIPS waiver: there's more to the story than vaccine patents
By Siva Thambisetty, Hyo Yoon Kang & Jocelyn Bosse
Waiver of patent rights on Covid-19 vaccines, in near term, may be more symbolic than substantive
By Helen Branswell, Matthew Herper & Damian Garde
Explained: Intellectual property waiver for Covid-19 vaccines
By Prabha Raghavan & Aanchal Magazine
Why the TRIPS Waiver Objections Don't Add Up
By Neal Templin
Covid: The vaccine patent row explained
By Dharshini David
U.S. wants COVID vaccine patent waiver to benefit world, not boost China biotech
By Carl O'Donnell, David Lawder & Andrea Shalal-Esa
Germany rejects U.S. proposal to waive patents on COVID-19 vaccines
By Madeline Chambers, Andreas Rinke & Douglas Busvine
U.S. reverses stance, backs giving poorer countries access to COVID vaccine patents
By Jeff Mason, David Lawder & Andrea Shalal-Esa
U.S. backs waiving patent protections for Covid vaccines, citing global health crisis
By Thomas Franck, Kevin Breuninger & Amanda Macias